Q32 Bio Current Assets

Q32 Bio (QTTB) currently reports a current assets of $57M as of March 2026. That compares with $69M in the prior-year period — down 16.7% year over year. Use the charts on this page to explore Q32 Bio's current assets history and peer comparisons.

Q32 Bio's current assets decreased from $69M to $57M — a 16.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Q32 Bio reported $57M in current assets as of March 2026. That compares with $69M in the prior-year period — down 16.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $57M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Q32 Bio, and consider following QTTB for alerts when major investors trade the stock.

Q32 Bio is classified in the Healthcare sector. On current assets, it currently shows $57M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing QTTB with unrelated industries.